Skip to main content
Clinical Trials/CTRI/2020/10/028438
CTRI/2020/10/028438
Not yet recruiting
Phase 3

Perspective of cancer patient in COVID-19 pandemic: an obsevational study

nil0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
nil
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
nil

Eligibility Criteria

Inclusion Criteria

  • Ability to read, write, or comprehend spoken language will be a prerequisite for entry into this study. The questionnaire will be filled out by either the patient or a family member if the patient is unable to read.

Exclusion Criteria

  • Patients will be excluded if they are in severe physical distress because of cancer or therapy\- related complications, in altered sensorium, are not receiving any active systemic therapy and oral targeted therapy, has no evidence of disease recurrence or progression, are planned only for best supportive care, and are being considered an inpatient admission for supportive care.

Outcomes

Primary Outcomes

Not specified

Similar Trials